logo-loader
viewCircassia Group PLC

Circassia Group Plc - Block Listing Application

RNS Number : 2345N
Circassia Group Plc
18 May 2020
 

18 May 2020

Circassia Group plc

Block Listing Application

Circassia Group plc ("Circassia" or "the Company") today announces that an application (the "Application") has been made to the London Stock Exchange for a block listing of 980,000 ordinary shares of 0.08 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM.

The Application relates to Ordinary Shares to be issued from time to time in order to satisfy the potential exercise of share options granted under the 2017 Performance Share Plan Scheme.

It is expected that admission will become effective on 22 May 2020. When issued, the Ordinary Shares will rank pari passu with the existing ordinary shares of the Company.

-Ends-

For further information, please contact:

Circassia Group plc

c/o Peel Hunt

Michael Roller, Company Secretary




Peel Hunt (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel / Oliver Jackson




finnCap (Joint Broker)

Tel: +44 (0) 20 7220 0500

Geoff Nash / Alice Lane




Numis Securities (Joint Broker)

Tel: +44 (0) 20 7260 1000

James Black / Duncan Monteith


 

                                                                                                     

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ALSFLFLFEAITLII

Quick facts: Circassia Group PLC

Price: 25.55

Market: LSE
Market Cap: £96.3 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Circassia Pharmaceuticals' commercial development...

Circassia Pharmaceuticals PLC's (LON:CIR) CEO Steve Harris tells Proactive London's Andrew Scott they saw strong growth in the first half of the year alongside a reduction in costs and cash outflows. Revenues for the six months ended June 30 were up 40% year-on-year at £27.9mln, with the...

on 26/9/19